LOMBARDI, Carlo Mario
 Distribuzione geografica
Continente #
NA - Nord America 7901
EU - Europa 4064
AS - Asia 1456
OC - Oceania 14
SA - Sud America 10
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13459
Nazione #
US - Stati Uniti d'America 7873
CN - Cina 1279
UA - Ucraina 1251
PL - Polonia 1054
IT - Italia 475
DE - Germania 466
IE - Irlanda 251
FR - Francia 150
GB - Regno Unito 136
FI - Finlandia 115
SE - Svezia 82
IN - India 68
TR - Turchia 41
VN - Vietnam 36
BE - Belgio 33
CA - Canada 26
RU - Federazione Russa 18
NL - Olanda 16
AU - Australia 14
ID - Indonesia 7
EU - Europa 6
MU - Mauritius 6
BR - Brasile 5
SA - Arabia Saudita 5
CL - Cile 3
ES - Italia 3
IR - Iran 3
RO - Romania 3
SG - Singapore 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
JP - Giappone 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BY - Bielorussia 1
CH - Svizzera 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
HK - Hong Kong 1
HT - Haiti 1
HU - Ungheria 1
IQ - Iraq 1
LK - Sri Lanka 1
LV - Lettonia 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 13459
Città #
Fairfield 1274
Warsaw 1053
Jacksonville 923
Woodbridge 813
Houston 600
Chandler 585
Ashburn 555
Cambridge 533
Seattle 524
Wilmington 523
Ann Arbor 483
Princeton 471
Nanjing 311
Dublin 251
Beijing 234
Nanchang 100
Des Moines 99
Dearborn 85
San Diego 85
Shenyang 85
Changsha 83
Hebei 78
Brescia 75
Tianjin 58
Jiaxing 57
Jinan 55
Dong Ket 36
Kocaeli 36
Milan 36
Brussels 31
Kunming 31
Lancaster 29
Verona 27
Hangzhou 26
Ningbo 25
San Francisco 24
Rome 22
Taizhou 20
Zhengzhou 20
Haikou 18
Orange 17
Guangzhou 15
Lanzhou 15
Toronto 13
Boardman 12
London 10
Canberra 8
Hanover 8
Norwalk 8
Helsinki 7
Phoenix 7
Prevalle 7
Shanghai 7
Taiyuan 7
Turin 7
Novara 6
Catania 5
North York 5
Peccioli 5
Riyadh 5
Strasbourg 5
Augusta 4
Changchun 4
Chicago 4
Hefei 4
Ottawa 4
Palermo 4
Redwood City 4
Reggio Nell'emilia 4
Rende 4
San Mateo 4
Borgaro Torinese 3
Bratislava 3
Brindisi 3
Calolziocorte 3
Fuzhou 3
Melbourne 3
New York 3
Nürnberg 3
San Nicola 3
Sydney 3
Amsterdam 2
Bergamo 2
Bologna 2
Calcinato 2
Catanzaro 2
Civitavecchia 2
Costa Mesa 2
Dallas 2
Florence 2
Genova 2
Groningen 2
Indiana 2
Iseo 2
Leawood 2
Lincoln 2
Ljubljana 2
Monzambano 2
New Delhi 2
Olginate 2
Totale 10661
Nome #
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 257
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 235
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 220
May 2020 at a glance: ischaemic heart failure and sex-related differences 207
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 198
Can we improve the treatment of congestion in heart failure? 196
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 195
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 191
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 172
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 146
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 132
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 130
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 129
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 124
Amino acids and derivatives, a new treatment of chronic heart failure? 119
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 119
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 116
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 115
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 108
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 101
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 101
The management of acute heart failure. 99
N-3 PUFA increase bioavailability and function of endothelial progenitor cells 98
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 97
Neurohormonal activation in acute heart failure: results from VERITAS 95
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 95
Heart failure and anemia: Effects on prognostic variables 94
Prognostic value of the absolute lymphocyte count in patients admitted for acute heart failure 94
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 93
The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy 92
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 91
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 91
Can we prevent or treat renal dysfunction in acute heart failure? 90
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 90
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 90
N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure 89
Echocardiographic elastic properties of ascending aorta and their relationship with exercise capacity in patients with non-ischemic dilated cardiomyopathy 88
Serelaxin a novel treatment for acute heart failure 88
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. 87
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 87
Exercise performance is a prognostic indicator in elderly patients with chronic heart failure: Application of metabolic exercise cardiac kidney indexes score 87
Anemia and heart failure : a cause of progression or only a consequence? 85
Role of fluid retention in patients hospitalised for acute heart failure. 84
Prediction of 1-year outcomes after an acute heart failure hospitalisation: importance of variables measured at the time of discharge. 84
Red cell distribution width and chronic heart failure: prognostic role beyond echocardiographic parameters. 84
Novel insight into the dangerous connection between diabetes and heart failure 83
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 83
Six-year prognosis of diabetic patients with coronary artery disease. 82
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. 82
A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure 82
The need for evaluating right ventricular adaptation and ventriculo–arterial coupling 82
Is there a role for ivabradine beyond its conventional use? 81
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 81
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 80
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 79
Mode of death and hospitalization from the second follow-up serial infusions of nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes 79
Nutritional Deficiency in Patients with Heart Failure. 79
Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis 79
Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health 79
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure 78
Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? 78
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 78
Long-term prognostic value of peak VO2 in patients with heart failure on chronic beta-blocker therapy. 76
Early readmission for heart failure: An avoidable or ineluctable debacle? 76
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: early in vivo cardiovascular effects 75
Successful switch to sitaxsentan in a patient with HIV-related pulmonary arterial hypertension and late intolerance to nonselective endothelin receptor blockade 73
Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome 73
Cardiorenal Interactions 72
Iron deficiency in heart failure 72
Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation 72
De novo acute heart failure and acutely decompensated chronic heart failure: one single syndrome or two different entities? 71
In-hospital worsening heart failure in patients admitted for acute heart failure 71
Preoperative cardiac risks in noncardiac surgery: The role of coronary angiography 71
Updates in heart failure: what last year brought to us 71
Carnosine: Potential aid for diabetes and cardiovascular disease 70
Dobutamine stress echocardiography in pulmonary arterial hypertension 70
Assessment of Congestion in Acute Heart Failure: When Simplicity Does Not Go Along With Accuracy 70
Effect of bosentan on exercise capacity and clinical worsening in patients with dual Down and Eisenmenger syndrome 69
September 2019 at a glance: focus on devices 69
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 68
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial) 65
Le pressioni di riempimento ventricolari e la risposta ventilatoria allo sforzo identificano i pazienti con insufficienza cardiaca ad alto rischio di eventi nonostante la terapia beta-bloccante. 62
Apnee notturne e insufficienza cardiaca: un problema in via di soluzione. 61
Arterial Stiffness And Ventricular-Arterial Coupling In Hfref. 59
Treatment of Patients Recently Admitted for Acute Heart Failure Based on NT-proBNP Plasma Levels Measurements. Results of a Prospective, Randomized, Single-centre Trial 58
Valore prognostico delle variazioni dell'indice di distribuzione dei volumi eritrocitari (RDW) nello scompenso cardiaco cronico. 57
Reversal by the selective D2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensive patients. 57
Cardiac Involvement in a Patient with Coronavirus Disease 2019 (COVID-19) 57
Le pressioni di riempimento ventricolari e la risposta ventilatoria allo sforzo identificano i pazienti con insufficienza cardiaca ad alto rischio di eventi nonostante la terapia beta-bloccante 56
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 56
Acute heart failure: The heart failure patient's journey-the vulnerable phase: Bibliography of one hundred key papers 55
Acute heart failure 55
Body Mass Index Paradox In Acute Herat Failure 55
Highlights in heart failure 55
Peak VO2 as a long term prognostic predictor in chronic heart failure patients on beta-blocker theraphy. 54
Variabili prognostiche in pazienti ospedalizzati per scompenso cardiaco acuto: esperienza di un singolo centro. 53
Intropic therapy independently associated with increased mortality only in the patients with acute heart failure and coronary artery disease. 52
Arrhythmias and cardiomyopathy: when arrhythmias come first 52
School and family-based interventions for promoting a healthy lifestyle among children and adolescents in Italy: A systematic review 52
Right heart dysfunction: from pathophysiologic insights to therapeutic options: a translational overview 52
Totale 9260
Categoria #
all - tutte 33429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33429

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018271 0000 00 1430 612211034
2018/20191753 23524232 19680 193203 42181337372
2019/20204105 629153144411 220448 350427 273574206270
2020/20213408 125450100425 237400 115372 371384269160
2021/20221735 8226447120 5288 50152 86205175414
2022/20231206 27410430130 173491 40 0000
Totale 13805